Concert Announces Clinical Advisory Board, New Medical Policies [Yahoo! Finance]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
NASHVILLE, Tenn. May 1, 2024 /PRNewswire/ -- As part of its commitment to provide transparent, evidence-based medical policy and enable accurate reimbursement for a broader set of diagnostic services, Concert today announced the establishment of an advisory board of experts in clinical laboratory medicine and the release of policies for an expanded scope of routine and advanced laboratory testing. The newly formed board will advise Concert on its clinical laboratory content. Members include Drs. Beth Harris Thomas Holland Girish Putcha , and Michele Schoonmaker . Details on each board member appear below. "Expanding the expertise that informs our content means Concert can bring transparency and efficiency to a broader set of health services, while keeping our solutions tightly linked to the latest evidence and guidelines," said Gillian Hooker , Concert's Chief Scientific Officer. "We are thrilled Drs. Harris, Holland, Putcha, and Schoonmaker have decided to join us in this effort
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Integrated DNA Technologies and Molecular Health Ink Commercial Partnership [Yahoo! Finance]Yahoo! Finance
- Oligonucleotide Synthesis Market is Expected to Reach $19.7 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Food and Beverage Manufacturers Can Overcome Condensation Challenges with Inkjet Printing and Laser Marking [Yahoo! Finance]Yahoo! Finance
- Blood Culture Tests Market Anticipated to Reach New Heights - the Market to Worth $8.98 Billion by 2029 - Exclusive Research Report by Arizton [Yahoo! Finance]Yahoo! Finance
- Gene Synthesis Technology and Global Markets Report 2023-2028: Technological Innovations and Implications for Healthcare, Research, and Beyond [Yahoo! Finance]Yahoo! Finance
DHR
Earnings
- 4/23/24 - Beat
DHR
Sec Filings
- 5/15/24 - Form 4
- 5/14/24 - Form 144
- 5/13/24 - Form 4
- DHR's page on the SEC website